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NMDA-receptor antibodies (NMDAR-Abs) cause an autoimmune en-
cephalitis with a diverse range of EEG abnormalities. NMDAR-Abs are
believed to disrupt receptor function, but how blocking this excit-
atory synaptic receptor can lead to paroxysmal EEG abnormalities—or
even seizures—is poorly understood. Here we show that NMDAR-Abs
change intrinsic cortical connections and neuronal population dynam-
ics to alter the spectral composition of spontaneous EEG activity and
predispose brain dynamics to paroxysmal abnormalities. Based on
local field potential recordings in a mouse model, we first validate a
dynamic causal model of NMDAR-Ab effects on cortical microcircuitry.
Using this model, we then identify the key synaptic parameters that
best explain EEG paroxysms in pediatric patients with NMDAR-Ab
encephalitis. Finally, we use the mouse model to show that NMDAR-
Ab–related changes render microcircuitry critically susceptible to
overt EEG paroxysms when these key parameters are changed,
even though the same parameter fluctuations are tolerated in the
in silico model of the control condition. These findings offer mech-
anistic insights into circuit-level dysfunction induced by NMDAR-Ab.
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The recent incorporation of novel cellular-based moleculardiagnostics into clinical practice has transformed our ability to
identify molecular disruptions of synaptic functions as the cause for
a range of neurological disorders (1). For example, antibodies to
NMDA receptors (NMDAR-Abs) have been identified as an im-
portant cause of autoimmune encephalitis (2), with a particularly
high incidence (∼40% of patients) in children (3). Patients show a
diverse range of symptoms including behavioral changes, move-
ment disorders, and seizures (3, 4). Electroencephalography (EEG)
abnormalities have been reported in up to 90% of patients un-
dergoing EEG monitoring; between 20–60% of patients also have
epileptiform discharges or electrographic seizures (5, 6). While
some EEG features are relatively specific for NMDAR-Ab en-
cephalitis (e.g., extreme delta brush) (6), most are nonspecific, with
more global abnormalities associated with more severe disease (7).
NMDAR-Abs mainly affect glutamate transmission through
reversible loss of NMDARs, resulting in a reduction of miniature
excitatory postsynaptic currents (mEPSCs) in brain slices (8, 9).
NMDAR hypofunction is also a hallmark of psychiatric conditions
such as schizophrenia and acute psychosis (10, 11) whose clinical
features resemble the neuropsychiatric symptoms also seen in early
NMDAR-Ab encephalitis. At the whole-organism level, NMDAR-
Abs caused an increased seizure susceptibility: Passive transfer of
patient Ig containing NMDAR-Abs into a mouse model caused
increased susceptibility to chemically induced seizures (12).
Linking NMDAR hypofunction at the cellular level and a
predisposition to seizures at the systemic scale is challenging. In
the simplified view of epileptic seizures as a consequence of ex-
citation–inhibition imbalance (13), one would expect NMDAR
hypofunction to be associated with a reduction of excitation and
thus a decrease in seizure susceptibility. While NMDARs are
ubiquitous across central synapses, there is differential expression of
NMDARs across neuronal populations (14, 15). Therefore, when
considering integrated neuronal ensembles, changes in NMDAR
function at the level of a single synapse may have a multitude of
different emergent effects depending on the combined influence on
both excitatory and inhibitory components of the neuronal circuit.
Observations in a range of experimental models motivate several
mechanistic hypotheses explaining the emergent effects of NMDAR
hypofunction. These include (i) altered excitatory dynamics with a
reduction in late excitatory postsynaptic potential components (9);
(ii) secondary neurotoxicity reducing the number of functional ex-
citatory connections (16); and (iii) a reduction of cortical inhibitory
interneuron activity (17). Furthermore, paradoxical changes in
excitatory and inhibitory transmission resulting from maladaptive
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homeostatic changes have been proposed as underlying NMDAR-
Ab–associated abnormalities at different temporal scales (8).
In a highly nonlinear dynamic system, such as the brain, the link
between synaptic abnormalities and whole-brain responses is rarely
intuitive or predictable. Neuronal systems are hierarchically struc-
tured, and each observational scale is constrained by larger-scale
processes as well as interacting with emergent properties arising
from smaller scales (18). Some of these multiscale dynamics can be
successfully captured in computational models of neuronal pop-
ulations, and have been integrated into validated analytic frame-
works, such as dynamic causal modeling (DCM) (19).
DCM rests on mesoscale neural mass models that capture the av-
erage behaviors of neural populations at the scale of a cortical column.
The model used here is representative of generic features of layered
cortex referred to as the “canonical microcircuit” (CMC) (20). Its pa-
rameters describe synaptic connection strengths and population re-
sponse dynamics and can be fitted to macroscale neurophysiological
recordings such as EEG or LFP recordings. Competing models
can then be ranked according to their Bayesian model evidence.
We have chosen this model for two reasons. (i) It directly
builds on models that have a long history in linking neurobiology
to the dynamics of EEG during epileptic seizures (21, 22). These
neural mass models constitute neuronal oscillators (i.e., re-
ciprocally coupled inhibitory and excitatory populations) as well
as incorporating some key interlaminar connectivity patterns
observed across a range of different cortical areas (23, 24). (ii)
The addition of a second pyramidal cell population in this par-
ticular model affords a greater diversity of neuronal dynamics by
allowing a separation in time scales between superficial and deep
neuronal oscillators, as also observed in empirical laminar re-
cordings (25). In addition to the microcircuit structure, the prior
values for the parameters are based on empirical measurements
accessible in the literature, where possible (26).
The themes of cortical laminar organization recapitulated in the
CMC are conserved across many mammalian species (27). This
underpins the use of these models in a range of different experi-
mental systems, ranging from LFP recordings in rodents to invasive
recordings in nonhuman primates and EEG/magnetoencephalo-
graphic recordings in human subjects (28, 29). Here we exploit this
conservation by combining measurements from invasive recordings
in a rodent model of NMDAR-Ab encephalitis and human patient
EEG recordings at the level of CMC parameters. We report the
results of a DCM analysis of (i) changes in spontaneous activity in a
mouse model of NMDAR-Ab encephalitis and (ii) abnormal EEG
paroxysms observed in a series of pediatric patients. We first model
the NMDAR-Ab effect in the mouse model using DCM to identify
a minimal set of synaptic parameters required to produce the
NMDAR-Ab effects on ongoing neuronal oscillations. Based on
patient EEG data, we then estimate fluctuations in the parameters
that explain the patient recordings. We are especially interested in
how changes in the different neuronal coupling parameters in com-
bination yield intermittent abnormalities typically recorded in pa-
tients. We leverage experimental control (afforded by the animal
model) to characterize spontaneous paroxysmal abnormalities (ob-
served in patient recordings): Operationally, we reproduce the pa-
rameter changes that explain human EEG paroxysms in the in silico
models of experimental effects in mice. This allows us to identify the
specific conditions that are necessary for EEG paroxysms to emerge.
Understanding this neuronal context for EEG abnormalities may
help improve targeted therapeutic approaches in the future.
Results
NMDAR-Abs Alter the Dynamic Response to Acute Chemoconvulsants
in Mice. Cortical dysfunction associated with NMDAR-Abs was
tested in C57BL/6 mice using a two-by-two design. This design
tested for the effects of NMDAR-Abs (delivered via intra-
cerebroventricular injection), the acute chemoconvulsant pen-
tylenetetrazole (PTZ, delivered via a later i.p. injection), and
their interaction. LFPs were recorded wirelessly in freely be-
having animals; 45 min of recordings pre- and post PTZ injection
of eight NMDAR-Ab–positive and five control animals were
included for the analysis reported here.
Antibodies alone caused a moderate suppression of the LFP
signal across low-frequency bands (delta and theta range) in the
NMDAR-Ab–positive mice. However, additional exposure to PTZ
revealed a marked difference between NMDAR-Ab–positive and
control mice, with a large increase of low-frequency (delta-band, 1–
4 Hz) power only in the antibody-positive PTZ-treated mice (Fig.
1). ANOVA revealed a significant main effect of NMDAR-Abs on
log-delta-band power [F(1,4601) = 9.67; P = 0.002] and a significant
interaction between NMDAR-Abs and PTZ exposure [F(1,4061) =
85.05; P < 0.001]. A PTZ-induced increase in paroxysmal fast
activity consistent with epileptic seizures was observed in the
NMDAR-Ab–positive IgG-treated mice compared with control
animals, as previously reported elsewhere (12), but this did not
produce a spectral difference in the frequency range analyzed
here (Fig. 1). An example of induced, nonepileptiform slow ac-
tivity is seen in Fig. 1B, Lower. These slow-wave cortical dynamic
abnormalities were further analyzed in the modeling below.
NMDAR-Abs Potentiate PTZ-Induced Effects in Cortical Microcircuitry
in Mice. To explain the observed differences in spontaneous ac-
tivity, hierarchical DCM was used to infer parameter changes
associated with the experimental variables over time (i.e.,
NMDAR-Ab exposure, PTZ infusion, and an Ab–PTZ inter-
action). In brief, a sliding window (length, 30 s; step size, 15 s)
was used to estimate the mean power spectra over successive
time points. Each time window was then modeled as the steady-
state output of a CMC model (20) with fixed synaptic parameters
for the duration of a single time window. By repeating this
analysis over windows, we identified fluctuations in synaptic
parameters that corresponded to the experimental interventions.
Across windows, the evolution of spectral patterns was captured
well for all experimental conditions (Fig. 2 A and B). To infer
experimental effects on DCM parameters, the sequence of pa-
rameter estimates was then modeled using a parametric empir-
ical Bayesian (PEB) approach (30). Here, slow fluctuations of
cortical coupling were modeled as between-window changes in
the synaptic parameters estimated within-window [see Papadopoulou
BA
Fig. 1. NMDAR-Abs alter the spectral composition of resting-state activity
following PTZ administration. Average Fourier spectra of LFP recordings of
endogenous activity in mice are shown. (A) In control animals, PTZ injections
cause a small decrease in low-frequency power. (B) In NMDAR-Ab–positive
IgG-treated animals, PTZ causes a profound increase in low-frequency
power, which is also visible as high-power slow waves in segments largely
without overt epileptiform activity (example shown). Average Fourier
spectra across animals are shown for 45-min recordings pre- and post-PTZ
injections. Shading indicates the 95% CI. Insets show Fourier spectra for a
broadband frequency range. Examples of 5-s LFP segments are also shown
for individual animals pre- and post-PTZ injections.
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et al. (28) for a worked example]. We included three main ex-
perimental effects of interest: (i) NMDAR-Ab, (ii) PTZ, and (iii)
an NMDAR-Ab × PTZ interaction term (Fig. 2C).
The neuronal parameters that affect the spectral composition of
spontaneous neuronal activity correspond roughly to the mecha-
nistic hypotheses outlined above: (i) time constants of the neuro-
nal populations (τ) describe the dynamics of neuronal population
responses; (ii) excitatory coupling parameters (ge) describe the
strength of excitatory between-population connections; (iii) in-
hibitory coupling parameters (gi) represent the strength of inhibitory
between-population connections; and modulatory coupling param-
eters (gm) represent the strength of inhibitory self-connections (20).
Spectral changes associated with NMDAR-Ab, PTZ exposure,
and their interaction were each explained by several corre-
sponding parameter changes. The biggest effects were associated
with PTZ exposure, with a decrease in the superficial pyramidal
cell population time constant (i.e., a faster return to baseline
after perturbation), an increase in the spiny stellate population
time constant (i.e., a slower return to baseline after perturba-
tion), and an increase in the excitatory connectivity from spiny
stellate to superficial pyramidal cells. Notably those changes
were further potentiated by NMDAR-Abs and the NMDAR-
Ab × PTZ interaction (Fig. 2D).
Shifts in Synaptic Dynamics Underlie the Emergence of Low-
Frequency Power in Mice. We further investigated the effect of
changes in synaptic parameters on the main spectral data feature
of interest, delta-band power. For this, we first performed a
principal component analysis over the slow (between-time win-
dow) parameter fluctuations separately for time constants and
connection strengths, retaining the first principal component of
each (Fig. 3 A and B). This analysis showed that most of the
variance over time can be explained by fluctuations in a small
subset of parameters, specifically, the time constants of superfi-
cial pyramidal and spiny stellate cells and the excitatory coupling
between them (as is also apparent in the analysis in Fig. 2).
We use these two components to project synaptic parameter
estimates at each time window onto the two dimensions explaining
most of the variance (i.e., one time-constant component and one
connection-strength component). To characterize different loca-
tions in this parameter space in terms of the neuronal dynamics
generated by the parameters, we used the mean delta-band power
of the predicted power spectral density. This functional char-
acterization of parameter space is shown (in log-scale) with a
color code and as isoclines indicating mean delta-band power
centiles (Fig. 3C). While there is variation in delta-band power
associated with both the time-constant (x axis) and the connection-
strength (y axis) parameters, the time constants have the greatest
effect on delta power. The difference between controls and
NMDAR-Ab–positive animals in the delta-band power post-PTZ is
largely conferred by shifting the time-constant component, causing
it to cross the 75th delta-band power centile much more frequently
than in controls (Fig. 3D). This differential effect of PTZ can be
seen by comparing the orange and purple dots in Fig. 3C.
EEG Paroxysms in Patients Are Caused by Fluctuations in Synaptic
Dynamics. To identify which synaptic parameters cause the par-
oxysmal EEG abnormalities commonly observed in NMDAR-Ab
encephalitis, we used the above CMC model to perform a DCM
analysis of eight pediatric cases for which EEG recordings
A
C
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Fig. 2. Synergistic changes in synaptic coupling explain the effects of PTZ and
NMDAR-Ab. (A and B) DCMs were fitted to sliding-window power spectral
density summaries of LFP recordings separately for control (A) and NMDAR-Ab–
positive (B) animals. (Upper) Observed power spectra over time. (Lower) Model
fits. (C) A second-level general linear model was used to estimate parameter
changes associated with NMDAR-Ab exposure, PTZ, and their interaction. The
regressors for the three main effects are shown. (D) These experimental effects
are associated with parameter changes across all populations of the CMC neural
mass model. (Left) The population-specific synaptic time constants that param-
eterize the temporal dynamics of postsynaptic responses within that population.
(Right) Excitatory connections between populations, inhibitory connections be-
tween populations, or self-inhibitory connections. (Center) Each of the param-
eters is modulated by each of the experimental effects. The strongest effects are
caused by PTZ, with the biggest associated changes in superficial pyramidal cell
and spiny stellate cell time constants and excitatory connection strength 4.
These changes are further potentiated by NMDAR-Ab exposure. Error bars in-
dicate Bayesian 95% CIs. dp, deep pyramidal cells; ii, inhibitory interneurons; sp,
superficial pyramidal cells; ss, spiny stellate cells.
Free parameters fitted by the DCM
Neuronal population time constant
τ1 superficial pyramidal cell time constant
τ2 spiny stellate time constant
τ3 inhibitory interneuron time constant
τ4 deep pyramidal cell time constant
Coupling parameter
g1 superficial pyramidal cell to spiny stellate cell inhibition
g2 inhibitory interneuron to spiny stellate cells inhibition
g3 inhibitory interneuron to deep pyramidal cell inhibition
g4 spiny stellate cell to superficial pyramidal cell excitation
g5 spiny stellate cell to inhibitory interneuron excitation
g6 deep pyramidal cell to inhibitory interneuron excitation
g7 superficial pyramidal cells self-modulation
g8 spiny stellate cell self-modulation
g9 inhibitory interneuron self-modulation
g10 deep pyramidal cell self-modulation
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were available and contained visually apparent EEG paroxysms.
Briefly, routine visual EEG analysis to identify paroxysmal
abnormalities was performed by two EEG-trained clinicians
(R.E.R. and G.C.) (SI Appendix, Table S1). For each patient, 2-s
time windows containing spontaneous activity, short isolated
paroxysms, or rhythmic/ongoing epileptiform activity were
extracted and used for further analysis (Fig. 4A).
Cortical source estimation for the paroxysmal EEG activity
was performed, and “virtual electrode” responses were extracted
from the most active sources (31). For each patient, DCMs were
independently fitted to power spectral density averages of each
available condition (e.g., background, short paroxysms, and ongo-
ing rhythmic activity) (Fig. 4B). Individually fitted DCMs (with
near-perfect model fits) (Fig. 4C) were subsequently combined in
within-patient, between-condition hierarchical (PEB) models that
explained the condition-specific differences with changes in syn-
aptic time constants (τ), between-population inhibitory con-
nections (gi), between-population excitatory connections (ge),
or within-population modulatory connections (gm). Across partici-
pants, models explaining spectral differences as arising from dif-
ferences in time constants offer the best explanation of the virtual
electrode data (with an exceedance probability of >95%) (Fig. 4D).
NMDAR-Abs Alter the Response to Intrinsic Fluctuations in Synaptic
Dynamics. The DCM of human data provides us with an estimate
of brain-state–specific changes in synaptic parameters. From the
Bayesian model comparison of a set of reduced models, it
emerged that the differences in the EEG states in human pa-
tients are best explained through variations in neuronal pop-
ulation time constants. We extracted DCM parameter estimates
of these time-constant changes for each patient, yielding a set of
time-constant parameters that explain the transition from back-
ground to paroxysmal EEG states for each participant individ-
ually. From this matrix of time constants (four time constants in
eight participants with two or three EEG states), we extracted
the first principal components and applied them to the control
and the NMDAR-Ab–positive mouse-derived CMC model. Con-
ceptually, we are thus enforcing the same degree of time-constant
fluctuations estimated from the patient models to the in silico
microcircuits derived from the mouse experiments.
The differences between the parameter estimates from the
control and NMDAR-Ab–positive model result in different
spectral outputs even when the same time-constant changes are
applied. Overall, the NMDAR-Ab–positive context results in
higher delta-band power and less high-frequency power (Fig. 5 A
and B). Crucially, delta power was higher in the NMDAR-Ab–
positive model across a wide range of time-constant fluctuations
(Fig. 5C). Furthermore, small changes in the synaptic parameters
identified with the patient data cause large changes in delta power
in, and only in, the NMDAR-Ab–positive model. This is manifest
as low-frequency paroxysmal activity when the synaptic parame-
ters change slightly in the NMDAR-Ab–positive model but not in
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the control (Fig. 5D). Technically, this abrupt change in dynamics
with a small change in parameters is known as a “phase transition,”
suggesting that antibody-positive effects on synaptic coupling move
the network toward a critical regime in which small fluctuations in
synaptic time constants produce qualitatively different dynamics
(i.e., paroxysmal EEG abnormalities).
Discussion
This study reveals common synaptic mechanisms underlying a range
of electrophysiological disturbances associated with NMDAR-Abs in
a mouse model and in pediatric patients: NMDAR-Abs cause a shift
in cortical synaptic parameters that is associated with an increase in
low-frequency oscillations and which predisposes microcircuits to the
slow-wave paroxysms seen in the clinical EEG recordings.
NMDAR-Abs Are Associated with High-Amplitude Low-Frequency
Discharges. NMDAR-Abs cause changes in the spectral composi-
tion of the resting-state LFP of the mouse strain tested. These
differences are further revealed on additional exposure to PTZ,
with a large PTZ-induced increase in mean delta power in the
presence of NMDAR-Ab. This increase is largely due to in-
termittent rhythmic slowing without concurrent epileptic spikes.
Previous analysis of seizure events shows that NMDAR-Abs also
lower the seizure threshold (12), but seizure events fall largely
outside the frequency spectrum analyzed here. These observations
are in keeping with clinically reported EEG features, i.e., back-
ground slowing with or without additional slow-wave paroxysms.
In mouse models of NMDAR hypofunction, normal NMDAR
function in parvalbumin (inhibitory) interneurons is required for
gamma rhythm induction (32). Furthermore, persistent NMDAR
hypofunction confers an increase in resting gamma power with a
concurrent reduction in stimulus-induced gamma oscillations (33). In
the mouse model presented here, we did not see such a change in
gamma frequency power, which may reflect the modeled disease
stage: Patients with NMDAR antibody encephalitis progress through
distinct stages, initially presenting with neuropsychiatric symptoms
before developing a more severe encephalopathic syndrome associ-
ated with slowing of the EEG (34). The findings of our study relate
most closely to this second stage and thus may relate to a patho-
physiology distinct from neuropsychiatric NMDAR hypofunction. In
the early stages of disease, the antibody effects may be limited to the
inhibitory interneuronal system (10). However, during the enceph-
alopathic stages (including the emergence of paroxysmal EEG ab-
normalities and epileptic seizures), there may be more wide-ranging
effects across cell types that are partly recapitulated in our mouse
model.
An increase in the power of slow-frequency components in an
EEG or LFP recording is thought to be associated with increased
synchronization of local cortical firing, itself regulated by inter-
acting cortical and subcortical systems, e.g., thalamocortical
loops (35), brainstem monoamine arousal systems (36), and in-
trinsic cortical effects such as astrocytic regulation of synaptic
function (37). Firing synchrony can occur physiologically (e.g.,
during sleep), can be associated with nonspecific cortical dys-
function (e.g., in the context of an encephalopathy), or can be a
component of epileptic discharges (apparent in slow-wave com-
ponents in spike-wave discharges) (38).
Synchrony, by definition, is an emergent feature of population
dynamics rather than a property of any single neuron, but an
increase in cortical synchrony may arise from a whole range of
different coupling changes at the synaptic level. Many of these
can be captured in mesoscale models of neuronal ensembles
(39). The DCM approach uses this mesoscale modeling to identify
the changes underlying the emergence of hypersynchronous slow-
wave activity in the context of NMDAR-Ab.
NMDAR-Abs Cause Laminar-Specific Changes in Cortical Dynamics.
DCM rests on neural mass modeling of coupled neuronal oscilla-
tors that are described using specific synaptic parameters (e.g.,
connection strengths and time constants) (see table in text) and that
broadly resemble the laminar structure of the cortex. The neural
mass model of a single electromagnetic source contains two pairs of
coupled neuronal oscillators that support slower (deep oscillator:
deep pyramidal cells, inhibitory interneurons) and faster (superficial
oscillator: superficial pyramidal cells, spiny stellate cells) activity
(25). These populations model the dynamics of an integrated cor-
tical column. Individual parameters exert highly nonlinear effects on
the system’s output. The parameterization of these models is rooted
in biophysical properties of individual neurons but describes average
characteristics of populations of functionally related neurons, i.e.,
composite properties emerging from the features of individual cells.
At this mesoscale, PTZ and NMDAR-Abs produce synergistic
effects that result in excessive synchrony not seen in other experi-
mental conditions. Our results suggest that increases in low-frequency
power can be explained by a combination of (i) an increase in su-
perficial cortical excitatory coupling, largely associated with PTZ ex-
posure, and (ii) opposing changes in the dynamics of the superficial
oscillator pair (spiny stellate and superficial pyramidal cells) (Fig. 3).
The changes in synaptic dynamics align time constants in a
gradient along the CMC coupling chain, with the slowest time
constants in the deep pyramidal cells, the fastest time constants in
the superficial pyramidal cells, and gradual steps between. This
reduces the stepwise difference in time constants along the CMC
chain compared with the standard CMC configuration. This pa-
rameterization allows a dominant frequency to resonate across and
recruit the whole column, thus producing the high-amplitude slow-
frequency patterns observed. Thus, interestingly, slow-wave activity
appears to be under the control of the faster, superficial oscillator
pair in the CMC model, with both NMDAR-Abs and PTZ having
profound and relatively specific effects on their dynamics. This is in
keeping with observations from invasive recordings of slow-wave
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Fig. 4. EEG paroxysms in NMDAR-Ab encephalitis patients are best explained
as time-constant fluctuations. (A) For each individual patient, 2-s time win-
dows containing spontaneous activity, short EEG paroxysms, and, where
available, longer rhythmic EEG activity were extracted. (B) These fluctuations
were source localized, and virtual electrode time traces were extracted at the
estimated cortical source. Normalized power spectral density averages across
all time windows were then fitted using separate DCMs for each condition. (C)
The normalized spectral outputs of fitted DCMs show near-perfect overlap
with the observed spectral densities, illustrating that the fits provide good
explanations of the observed (spectral) data features. (D) We then used
Bayesian model reduction to test which subset of parameters best explains the
differences between the different EEG states across the whole group. For each
individual, between-condition effects were estimated in a number of reduced
(PEB) models that differed only in which parameters were free to explain the
between-window spectral variations. Of these PEB summaries of individual
participants, models explaining the spectral changes with fluctuations in time
constants have an exceedance probability of >95%.
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activity in human patients with epilepsy, which implicate superficial
cortical coupling in the regulation of slow-wave sleep activity (40).
Different Molecular Changes Show Converging Effects at the Neuronal
Population Level. The synaptic parameters of the CMC model
employed in DCM are population summaries of a variety of cellular
effects, encompassing emergent properties and multiple nonlinear-
ities (41). Time constants at the population level are essentially de-
scriptions of the dynamics of postsynaptic integration affected by
multiple factors, such as background firing frequency, membrane
conductance, intra- and extracellular ion composition, and the dy-
namics of receptor types present in the membrane, to name only a
few (42). Connection strengths at the population level summarize
the effect one population has over another. This may include effects
mediated through assumed subpopulations contained within the
modeled populations (e.g., self-connections are modeled as direct
connectivity but represent local intralaminar inhibitory interneuronal
inhibition). Because a number of different effects may converge on
the same population parameters, and individual molecular effects
may be expressed only in certain conditions, the link between mo-
lecular change and population parameters is nontrivial.
The approach presented here deliberately collapses much of the
diversity of cortical physiology into mathematical descriptions that
have specifically been developed to capture the sort of abnormal
responses observable in EEGs. This offers the opportunity to in-
tegrate findings from diverse sets of recordings into a common
mathematical framework describing ongoing cortical dynamics.
Exposure to NMDAR-Abs has been reported to cause a
number of changes in the postsynaptic glutamate response, in-
cluding a reduction in overall postsynaptic potential, a reduction
in late postsynaptic currents, and a faster return to baseline (8,
9). In intact neuronal circuits, NMDARs exert differential con-
trol over excitatory and inhibitory populations, leaving the pop-
ulations differentially affected by NMDAR blockade (43).
PTZ is believed to act as an antagonist to GABAA receptors
by directly blocking ionophores (44). GABAA receptors are fast
inhibitory receptors with a widespread region and cell-type spe-
cific set of postsynaptic effects (45). These include inhibitory
postsynaptic potentials but also inhibition of dendritic excitatory
postsynaptic potentials via extrasynaptic GABAA receptors, which
is particularly pronounced at the cortical pyramidal cells (46). In
some neuronal cell types and at certain developmental stages
GABAA can cause excitatory postsynaptic potentials (47), and
GABA transmission can exert direct or indirect control over ex-
citatory NMDAR-dependent synaptic transmission (48).
With this range of different cellular effects, it is unlikely one can
capture the breadth of NMDAR-Ab– and PTZ-related effects in a
small subset of population model parameters. However, the effects
on delta-band power can be reproduced well with a few principal
components comprising largely just two main effects: (i) decreasing
the time constants of superficial pyramidal cells relative to excit-
atory spiny stellate cells and (ii) increasing the excitatory coupling
between spiny stellate and superficial pyramidal cells.
A number of possible and convergent changes at the molecular
level associated with NMDAR-Ab and PTZ exposure could ex-
plain these population-level effects. The time-constant changes in
superficial pyramidal cells may result from being switched toward
(faster) AMPA-mediated excitatory inputs (due to the NMDAR-
Ab–mediated internalization of NMDAR) and a change in mem-
brane conductivity (due to PTZ-mediated blocking of extrasynaptic
GABAA receptors). The change in excitatory connection, on the
other hand, is consistent with a disinhibition of excitatory EPSPs
under GABAA blockade with PTZ (i.e., a block of so-called
“shunting inhibition”) (46). Furthermore, different inhibitory inter-
neuron populations characterized by different molecular markers,
morphology, and functional integration show distinct and at
times opposing overall effects on cortical dynamics (49). Thus,
features of neuronal dynamics that in our models appear as
changes in excitatory coupling at the population level may result
from subpopulation-specific changes in cortical (dis) inhibition.
Experimental methods to link detailed cell type-specific cortical
physiology and population dynamics exist in experimental animals
(50) but cannot be accessed directly in patient EEGs. By focusing
on the mesoscale descriptions here while enforcing a simplified
representation of cortical dynamics, we can describe the systemic
effects of NMDA Abs in recordings from the mouse model as well
as in patient EEGs. The increasingly detailed characterization of
mouse cortex circuitry provides an important focus for pro-
gressively refining these sorts of models in future studies.
Each of these changes at the molecular level (approximated
through the population-model parameters) has nonlinear effects on
neuronal responses. Thus, as in other complex systems, even small
fluctuations in the parameters induced by only a relative shift in the
balance of, e.g., AMPA receptor- and NMDAR-mediated trans-
mission can have profound effects on the activity of the dynamics of
the whole circuit. These effects can be quantified using a sensitivity
analysis, i.e., quantifying how changes in model parameters pro-
duce distinct spectral responses (SI Appendix, Fig. S1).
A
C
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Fig. 5. NMDAR-Abs sensitize the microcircuit to intrinsic fluctuations in time
constants. (A and B) Here, we apply a summary component of the time-constant
fluctuations estimated from human patients to a cortical microcircuit model de-
rived from the control mice (A) and the NMDAR-Ab–positive mice (B). The same
fluctuations cause spectral outputs containing much higher relative delta power in
the model estimated from NMDAR-Ab–positive mice. (C) This figure shows the log
of mean delta power for a range of smoothly increasing time-constant fluctua-
tions. In the low parameter range (−2.5 to −1.5), there is a large jump in delta
power, suggesting that there are two distinct dynamic states separated by small
differences in parameter values. (D) Examples of reconstructions of time series for
parameter values at two very close parameter values (p1 and p2) are shown for
control and NMDAR-Ab–positive models. The sudden increase in delta power is
visible as a paroxysmal change in the time series in the NMDAR-Ab–positive con-
text, while the control time series appears continuous. This sudden change in
dynamics with a small change in parameter space is known as a “phase transition.”
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NMDAR-Abs Sensitize the Cortical Column to Spontaneous Paroxysmal
EEG Abnormalities. In the patients with NMDAR-Ab encephalitis,
there is no experimental control over NMDAR-Ab exposure.
Furthermore, our sample of patients is heterogeneous, represen-
tative of clinical practice (e.g., varying in age, gender, timing of
EEG, timing of initial diagnosis, and other characteristics). How-
ever, these patients show a diverse range of paroxysmal, short-term
changes in EEG dynamic patterns that are visually apparent, allowing
us to probe spontaneous fluctuations of DCM parameters that
may underlie discrete pathological brain states.
Patient-specific modeling, as facilitated by DCM, allows in-
ference about patient-specific parameters in a generic model of
the cortical column. Thus, applying DCM analysis to this diverse
sample, one can access two types of results: (i) qualitative, i.e.,
identifying the parameters whose changes underlie the dynamic
abnormalities seen in EEG, and (ii) quantitative, i.e., establish-
ing the numerical range of parameter fluctuations that can be
applied to other specified DCMs.
Consistently across patients, models with changes in time con-
stants best explained the observed transitions between background
activity and paroxysms. Furthermore, we summarized these pa-
rameter changes along a single (principal component) axis. We
used this component to enforce similar fluctuations in the fully
specified DCMs derived from the mouse model analysis, asking
whether the baseline context (i.e., the parameterization derived
from NMDAR-Ab–positive or control animals) alters the impact of
parameter changes of the magnitude observed in human patients.
Indeed the dynamic responses of the two types of models are
very different. In the context of NMDAR-Ab, overall greater delta-
band power is observed, and there are regimes of parameter space
that contain boundaries between very different dynamic states (51).
This structural instability underwrites phase transitions of the sort
seen in seizure activity or other EEG state transitions. In the
control parameterization the same changes have a much less pro-
nounced effect and do not induce overt slow-wave paroxysms. In
short, it appears that paroxysmal EEG activity in patients may be
best explained by normal fluctuations in synaptic time constants
that occur in an abnormal regime of synaptic parameter space.
In the human patients we relied on EEG recordings that were
obtained in the absence of external experimental controls, ef-
fectively using the modeling to describe the kinds of neuronal
coupling changes that cause spectral shifts in the EEG as
observed during short-term paroxysms. Furthermore, dynamic
features observable in EEG are averages of larger-scale network
activity than the LFP recordings in mice. However, the insight
that the spectral shift induced by changes in these parameters
depends on NMDAR-Abs was afforded only through the ex-
perimentally constrained DCMs estimated from the animal
model. The translation between species and modalities is affor-
ded by explicit generative neuronal models that relate data
features to underlying neuronal population activity. In the case
of human EEGs, we first extract local cortical time series using a
virtual electrode, i.e., a beamformer source reconstruction al-
gorithm, before fitting mesoscopic neuronal populations models
using DCM. In the case of LFP recordings in mice, we can use
DCM directly to explain the recorded LFPs (with the observa-
tion model consisting of a single scalar gain parameter). Cru-
cially these generative models then allow neurobiologically
relevant features (i.e., changes in connection strength and synaptic
dynamics) to be translated at the same mesoscopic scales.
Overall, these findings provide integrative evidence from human
patients and a mouse model of NMDAR-Ab encephalitis suggest-
ing that (i) NMDAR-Abs cause electrophysiological abnormalities
via a small number of synaptic changes, which may lend themselves
to targeted therapeutic interventions, e.g., by exploiting laminar
and/or cell type-specific effects of transcranial current stimulation
(52), and (ii) paroxysmal abnormalities can be explained by per-
sistent baseline changes that render cortical microcircuitry partic-
ularly sensitive to (potentially normal) fluctuations in synaptic
coupling. Future research may reveal whether similar approaches
have diagnostic value when performed on patient EEGs alone (53).
Limitations. The modeling approach presented here allows unique
insights into possible mechanisms underlying empirically observed
phenomena. Although DCM has been applied to a wide variety of
neurophysiological studies, and its validity has been assessed repeatedly
(54, 55), there are certain limitations to the approach adopted here.
First, that modeling can be applied only to existing data places
restrictions on study design (e.g., pre–NMDAR-Ab exposure EEGs
are not usually available from patients) and limits the approach to a
subset of testable hypotheses. Second, like all inferences, DCM is
based on specific assumptions regarding the underlying neuronal
architecture. All activity presented here is presumed to emerge
from microcircuitry consistent with the CMCmodel, and only given
this assumption can we estimate the parameters and evidence for
or against specific model configurations.
Most importantly, we have reduced a complex brain-wide pa-
thology of interacting systems to changes in a cortical microcircuit.
Thus, we are ignoring interactions between different cortical regions
as well as the influence of subcortical structures, such as thalamus
and brainstem, which (especially in the context of encephalopathy
and slow-wave abnormalities) will exert a powerful influence over
cortical states. Although these effects can be accommodated in the
model as random effects, they are not modeled explicitly.
The approach here, by design, does not focus on single-cell dy-
namics but treats cortical patches as integrated units, which corre-
spond to the mesoscale dynamics observable in EEGs (18). Our
computational modeling of cortical microcircuits aims to link some
of these observed dynamics with the themes that have emerged from
detailed microanatomy and neurophysiology at the microscale and
are implicated in NMDAR-related pathology. However, we are not
attempting to make inferences about single neurons. The models
describe the net effect of NMDAR-Abs on integrated circuits of
neuronal populations; future studies should allow us to model how
those effects emerge from single-neuron interactions. Furthermore,
we note that many of the canonical models of cortical circuitry
(including ours) have focused on excitatory population coupling and
in the future may benefit from incorporating some of the more re-
cent themes that have been identified in the connectivity patterns of
inhibitory interneuronal populations (56). Our study aimed to an-
swer specific questions driven by observations in a particular pa-
thology related to NMDAR-Ab. While the models and results as
presented are appropriate for this focus, there are many observa-
tions related to abnormal NMDAR function that are not currently
captured in the model here. We hope that future research will in-
tegrate such experiments and observations and expect that genera-
tive models such as the one presented here will help in this work.
Methods
Our analysis uses DCM to infer the neurobiological parameters that underlie
electrophysiological changes in patients with NMDAR-Ab encephalitis and a
correspondingmouse model. Once these changes have been identified, we use
the fully parameterized in silico models in simulation mode to integrate the
findings and explore hypotheses about how NMDAR-Ab–induced changes in
the neurobiology cause the EEG abnormalities observed in patients.
For this, the analysis is broadly divided into three stages, which are explained
in detail below: (i) using DCM of LFP recordings in the mouse model (exploiting
the factorial experimental design), we estimate neuronal population coupling
in the cortical microcolumn induced by NMDAR-Abs (Fig. 6 A–D); (ii) in a cor-
responding DCM analysis of spontaneous EEG paroxysms recorded in human
patients, we estimate fluctuations in microcircuit coupling (Fig. 7); and (iii) we
implement these patient EEG-derived parameter fluctuations in the in silico
representations of microcircuits derived from control and NMDAR-Ab condi-
tions in the mouse experiment. This allows us to investigate the dynamics of the
microcircuits with and without NMDAR-Ab effects, testing whether the associ-
ation between certain model parameter shifts and paroxysmal spectral abnor-
malities (as observed in human patients) depend on specific dynamic contexts
(i.e., conditions in our mouse experiments) (Fig. 6 E–H).
Collection and Classic Analysis of Mouse LFP. The mouse model and associated
procedures have been previously described (12). Briefly, plasma with NMDAR-
Ab (IgG) was obtained with informed consent from three female NMDAR-Ab–
positive patients with neuropsychiatric features, movement disorder, and re-
duced level of consciousness; samples were deidentified before research use.
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Control IgG was purified from serum from two healthy individuals. C57BL/
6 female mice aged 8–10 wk were housed and examined according to Animal
Research: Reporting of in Vivo Experiments (ARRIVE) guidelines, and all
analyses were performed with the observer blinded to injected antibody.
Animal experiments were approved by a local ethical review committee at the
University of Oxford and performed under license from the UK Home Office in
accordance with the Animal (Scientific Procedures) Act 1986.
Wireless telemetry transmitters (s.c. transmitter A3028B-CC from Open
Source Instruments, Inc.) were implanted in an s.c. pocket over the right flank.
Two craniotomies were performed at 1 mm lateral and 1 mm caudal from
bregma. Electrode screws were fixed into the drilled holes with dental cement.
After a 5-d monitored recovery period, 8 μL of purified IgG (patient or control)
was injected slowly into the left lateral ventricle through a single additional
craniotomy made 1 mm left lateral and 0.45 mm caudal from bregma.
Mice were housed in a Faraday cage during wireless LFP data collection. To
test seizure susceptibility, 40 mg/kg of PTZ was given i.p., and the mice were
observed for 45 min following injection. The 45-min time period immediately
preceding PTZ injection was used as the control segment.
Raw LFP data were analyzed in Matlab. Sliding-window (30-s windows,
15-s steps) Fourier estimates of power over frequency were used to statis-
tically compare the different conditions. ANOVA over mean delta-band
power (1–4 Hz) was used to estimate the effects of the two main interven-
tions (NMDAR-Ab and PTZ) and their interaction on LFP signal composition.
Modeling Cortical Activity with the CMC Model. For the purposes of this analysis,
cortical activity is assumed to arise from a cortical microcolumn that consists of
four coupledneuronal populations: twomainoutputpopulations (superficial and
deep pyramidal cells) and local inhibitory and excitatory populations (inhibitory
interneurons and spiny stellate cells, respectively). Thesepopulations arebasedon
both established models of cortical function (22, 57) and empirically observed
connectivity patterns (26, 58, 59). These populations are organized into two
oscillator pairs: one superficial (consisting of superficial pyramidal cells and spiny
stellate cells) and one deep (consisting of deep pyramidal cells and inhibitory
interneurons). This architecture recapitulates generic themes in cortical organi-
zation while allowing a diverse range of dynamics enabled by the two coupled
oscillator pairs (see Fig. 2D for an illustration of the model architecture) (20).
Intralaminar connectivity is largely represented within neuronal pop-
ulations. Each population is parameterized by recurrent inhibitory self-connection
parameters, population time constants, and a parameterized sigmoid function
that models the dispersion of population responses. Interlaminar coupling is
modeled explicitly through population-level connectivity between populations.
Each oscillator pair has reciprocal excitatory and inhibitory connectivity. Note
that indirect inhibition from superficial pyramidal cells to excitatory interneu-
rons, mediated via assumed intralaminar inhibitory interneurons, is absorbed
into a direct inhibitory connection.
DCM Analysis of Mouse LFPs. Dynamic causal modeling was performed using
SPM12, an academic software package (https://www.fil.ion.ucl.ac.uk/spm/).
All analysis code and raw data are available online at https://www.doi.org/
10.17605/OSF.IO/YXKWD, which requires Matlab 2014b or later and SPM12.
Modeling of the mouse LFP recordings can be divided into the following
steps (summarized in Fig. 6):
i) Inversion of separate single-source DCM for each time window (per-
formed on group-average data)
ii) Second-level (PEB) modeling to explain parameter changes over time,
based on experimental interventions
iii) Forward modeling to explore the effects of parameter changes on spe-
cific output measures (e.g., delta power)
Individual timewindows were assumed to be relatively stationary within the
30-s sliding time window, in line with previous DCM analyses of EEG seizure
activity (29, 31). Each time window was modeled as originating from a single
cortical source comprising four coupled neuronal populations (i.e., a single
cortical columnmodeled as a single CMC). DCM employs a standard variational
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Fig. 6. Modeling approach to mouse LFP recordings.
Modeling was designed to extract relevant parame-
ters (A–D) and then explore the effects of those on
delta power (E–H). (A) For both pre- and post-PTZ in-
jection, 45 min of LFP recordings were extracted for
each mouse. A sliding window was used to extract a
sequence of time windows for further analysis. (B)
Power spectral densities were estimated for each time
window, which are the basis for the DCM model fit.
(C) Single-source DCMs comprising a single CMC
model were fitted to each time window separately.
(D) Using a PEB approach to fit a second-level
between-DCM general linear model, we extracted
parameter variations explained by specific experi-
mental effects and updated first-level DCM parame-
ters. (E) From the updated first-level DCMs, we
extracted all parameters and summarized them in two
principal components over time constants and con-
nection strengths, retaining the first component
summaries of the fitted DCMs. (F) Starting from the
baseline model specification, we applied the reduced
(i.e., first principal component) summaries of the pa-
rameter changes to simulating cross-spectral outputs
of the neural populations, yielding a map of delta
power across the ensuing 2D parameter space. (G) We
then applied quantitative parameter changes ob-
served in patient EEGs (summarized as their first
principal component) to the control and NMDAR-Ab
baseline model specifications to explore the effects of
parametric fluctuations on spectral output. (H) To
further illustrate the effects of parametric fluctua-
tions, we applied and inverse Fourier transform to
generate substitute time series, illustrating the nature
of the changes in a time trace.
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Laplace scheme to fit the parameters of a specified neural mass model to
empirical data (19) while also providing a free energy measure of the Bayesian
model evidence. The combination of posterior parameter estimates and free
energy subsequently allows computationally efficient modeling of group ef-
fects across individual DCMs, further exploited with the PEB analysis (30).
A second-level model, PEB, was used to estimate parameter changes as-
sociated with the experimental modulations. Specifically, each time window
was associated with a numerical value representing the absence or presence
of NMDAR-Ab (0 or 1, respectively), the estimated PTZ concentration (range
0–1, modeled as first-order kinetics after i.p. injection), and an interaction
term (range −1 to 1). PEB employs Bayesian model reduction based on the
specified model parameters, effectively modeling between-window changes
in parameter as a mixture of random effects and systematic modulation of
each parameter by the main effects provided in the PEB model specification.
Thus, inversion at the second (between-window) level provides posterior
parameter estimates for first-level model parameters (i.e., neuronal physi-
ology) that are associated with second-level parameters (i.e., experimental
modulation) across the whole series of individual DCMs.
Comparison betweenmodels is based on the free energy approximation of
the Bayesian model evidence. We use a Bayesian model reduction approach
that is computationally efficient and provides model evidence estimates for a
range of different models that differ in terms of the parameters that are free
to vary to explain between-window variation in the PEB analysis (30). This
approach provides a ranking of how well different combinations of free
parameters explain a given dataset (here consisting of between-window
changes in power spectral densities) and allows us to identify the most
parsimonious model for the observed EEG or LFP effects. Note that models
with the highest evidence are those that generalize, in virtue of the fact that
model evidence is the difference between accuracy and complexity.
The DCMs are fully specified models of spontaneous neuronal activity and
therefore can be used to explore individual parametric effects on overall spectral
output. Here, we utilize the parameter estimates derived as the groupmean in the
PEB analysis as baseline. We then extract the first principal components of time-
constant and connection-strength variations across all individual time window
DCMs (Fig. 6E), providing a summary of covarying changes in parameters that
explain most of the variance across samples. We then systematically vary the
contribution of each of these two components in 300 discrete steps each around
the baseline estimates. This yields 300 × 300 = 90,000 parameterizations for a
single source DCM, and for each of these the spectral output can be estimated.We
can use this to visualize scalar output measures (e.g., log mean delta-band power)
across a section of a 2D parameter space (Fig. 6F). This combines the benefits of
fitting generative (i.e., forward) models to empirical data and exploring the effects
of specific parameters on model output through forward modeling (60).
In a last step, we implement the microcircuit parameter fluctuations es-
timated from paroxysmal EEGs in patients in different conditions of the in
silico mouse model. Specifically, we
i) Estimate parameter changes that underlie paroxysmal EEG responses in
patients (discussed below);
ii) Take the first principal component of the variations of time constants
across all participants and EEG states to capture most of the variance of
time-constant changes; and
iii) Implement corresponding parameter changes across the range esti-
mated from human EEGs in mouse-derived in silico microcircuit models.
This allows us to simulate the kinds of spectral changes that would be
induced if the mouse-derived in silico microcircuits experienced the same
(spontaneous) fluctuations in model parameters as observed in human EEGs.
We then use an inverse Fourier analysis to illustrate the sort of paroxysmal
responses that would be expected based on the spectral predictions under
specific parameter combinations (Fig. 6H).
Patient Selection and EEG Recording. Patients were selected from routine
clinical service at a tertiary pediatric specialist hospital that is a regional referral
center for patients with presumed autoimmune encephalitis. Patients were
selected based on (i) symptoms consistent with autoimmune encephalitis,
(ii) positive laboratory testing for NMDAR-Abs at some point during their
clinical course, (iii) the availability of routine clinical EEG recordings during the
acute phase of their illness, and (iv) the presence of visually apparent EEG
abnormalities. Anonymized clinical information was provided by the patients’
care team with written, informed consent provided by the patients’ legal
guardians. All patients met the Graus criteria for a clinical diagnosis of NMDAR-
Ab encephalitis (61). Use of anonymized patient data was approved by the
United Kingdom Health Regulatory Authority (Application No. 229772).
All EEGs used in this analysis were standard clinical recordings (21 elec-
trodes, International 10–20 electrode layout, 30-min recording time, 256-Hz
sampling frequency, 1- to 70-Hz digital Butterworth bandpass filter). EEGs
were visually analyzed by two clinicians with expertise in EEG interpretation
(R.E.R. and G.C.), identifying paroxysmal abnormalities as well as segments
of artifact-free awake background EEGs that were used for further analysis.
DCM Analysis of Patient EEG Paroxysms. EEG analysis was designed to identify
mechanisms underlying the frequently observed paroxysmal abnormalities in
patients with NMDAR-Ab encephalitis. The purpose of this modeling ap-
proach is to identify a small set of parameters that can explain the transition
between background activity and EEG paroxysms for each individual patient.
The analysis can broadly be summarized as follows (also shown in Fig. 7):
i) Visual identification of paroxysmal and background EEG activity source
localization and virtual electrode source wave form extraction;
ii) Fitting single-source DCM to each virtual electrode summary of parox-
ysmal and background data; and
iii) Inversion of hierarchical (PEB) models explaining within-subject EEG
patterns through sets of reduced parameters, which then allows Bayesian
model comparison at the group level (random effects analysis).
Patients were selected based on clinical EEGs with reported dynamic ab-
normalities (ranging from evidence of mild encephalopathy to overt epi-
leptiform activity). EEGs were reviewed by two clinicians with EEG experience
(R.E.R. and G.C.), and segments containing normal awake background as well
as paroxysmal abnormalities (isolated slowwaves, intermittent rhythmic slow
activity, and overt epileptiform activity) were identified. Paroxysmal activity
was averaged across visually identified 2-s windows and was source localized
using an independent and identically distributed (IID) approach in SPM12
(62). At the cortical location with maximal activity, a single virtual electrode
trace was extracted for each of the paroxysmal and background activity
windows and was used for further DCM analysis (29). The virtual electrode
approach reconstructs the time course of signals at points on the cortical
mesh of a three-layer head model using an empirical Bayes beamformer
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Fig. 7. DCM analysis approach for patient EEG re-
cordings. (A) Visual analysis was performed to iden-
tify segments of artifact-free background EEG as well
as visually apparent paroxysms of abnormal activity
(which were further separated into isolated and
rhythmic abnormal activity). (B, Upper) This activity
was source localized using an IID approach. (Lower)
Subsequent modeling was performed using a virtual
electrode estimate of LFP activity at the identified
source. (C) Single-source DCMs comprising a single
CMC were fitted separately to power spectral density
averages of background and paroxysmal activities.
(D) PEB was employed to reduce within-subject dif-
ferences between individual DCMs to specific subsets
of parameters. The model space was designed to
distinguish between sets of models where time
constant, inhibitory connections, excitatory connec-
tions, or modulatory connections explained variations among conditions. (E) A random effects Bayesian model comparison between these alternative PEB
models helped identify which parameters best explain the fluctuations across the whole group of subjects.
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source reconstruction algorithm (63), thus providing LFP-like data that best
explain the more distributed activity observed on the scalp (62).
This virtual LFP activitywasmodeled using a single CMC source. An average
of all paroxysm timewindows and all background timewindows was inverted
separately, producing two to three fully specified DCMs per subject. These
were subsequently combined into a single hierarchical (PEB) model for each
patient in which only a subset of specific parameters was allowed to vary. A
model space was created at the level of these second-level models, where
either time constants, inhibitory between-population connections, excit-
atory between-population connections, or inhibitory self modulatory con-
nections were allowed to vary to explain the difference between paroxysms
and background activity (see in-text table). Random-effects Bayesian model
comparison across these second-level models uses the approximation to
model evidence from the variational Laplace model inversion (i.e., the free
energy) to compare the evidence for any given model parameterization,
given the empirical data (54).
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